Clinical Trial Update: Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran

View source ↗

Summary

Clinical trial update describing myocardial effects observed in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy (ATTRv-PN) treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Amyloidosis
• Transthyretin Amyloidosis

Drugs mentioned

• Patisiran (patisiran)
• Vutrisiran (vutrisiran)

Snippet

Sponsor: Rennes University Hospital | Conditions: Transthyretin Amyloidosis, Amyloidosis, Hereditary | Status: ACTIVE_NOT_RECRUITING